• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预防艾滋病的母婴疫苗接种研究。

Research on Maternal Vaccination for HIV Prevention.

机构信息

Department of Pediatrics, Weill Cornell Medicine, 413 East 69th Street, BB-869E, New York City, NY 10021, USA.

Department of Pediatrics, Weill Cornell Medicine, Drukier Institute for Children's Health, 413 East 69th Street, New York City, NY 10021, USA.

出版信息

Clin Perinatol. 2024 Dec;51(4):769-782. doi: 10.1016/j.clp.2024.08.007. Epub 2024 Sep 11.

DOI:10.1016/j.clp.2024.08.007
Abstract

Despite increased uptake of antiretroviral therapy (ART) among pregnant people living with human immunodeficiency virus (HIV), vertical transmission remains the most important route of pediatric HIV acquisition. The numbers of HIV acquisitions in infancy have remained alarmingly stagnant in recent years. It is evident that additional strategies that can synergize with ART will be required to end the pediatric HIV epidemic. In this review, we discuss the potential for immune-based interventions that can be administered in conjunction with current ART-based strategies to the birthing parent for prevention of vertical transmission of HIV-1, and the potential challenges associated with each approach.

摘要

尽管感染人类免疫缺陷病毒(HIV)的孕妇越来越多地接受抗逆转录病毒治疗(ART),但垂直传播仍然是儿童 HIV 感染的最重要途径。近年来,婴儿 HIV 感染的数量仍然惊人地停滞不前。显然,需要与 ART 协同作用的额外策略,才能终结儿童 HIV 流行。在这篇综述中,我们讨论了联合当前基于 ART 的策略,向分娩母亲提供免疫干预以预防 HIV-1 垂直传播的可能性,以及每种方法所涉及的潜在挑战。

相似文献

1
Research on Maternal Vaccination for HIV Prevention.预防艾滋病的母婴疫苗接种研究。
Clin Perinatol. 2024 Dec;51(4):769-782. doi: 10.1016/j.clp.2024.08.007. Epub 2024 Sep 11.
2
Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk.靶向V3环C末端区域的母体结合性和中和性IgG反应可预测围产期HIV-1传播风险降低。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02422-16. Print 2017 May 1.
3
Induction of Neutralizing Responses against Autologous Virus in Maternal HIV Vaccine Trials.诱导母体 HIV 疫苗试验中针对自身病毒的中和反应。
mSphere. 2020 Jun 3;5(3):e00254-20. doi: 10.1128/mSphere.00254-20.
4
Recent progress in immune-based interventions to prevent HIV-1 transmission to children.免疫干预措施预防儿童感染 HIV-1 的最新进展。
J Int AIDS Soc. 2017 Dec;20(4). doi: 10.1002/jia2.25038.
5
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
6
Coadministration of CH31 Broadly Neutralizing Antibody Does Not Affect Development of Vaccine-Induced Anti-HIV-1 Envelope Antibody Responses in Infant Rhesus Macaques.在恒河猴婴儿中,CH31 广谱中和抗体的联合给药并不影响疫苗诱导的抗 HIV-1 包膜抗体反应的发展。
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.01783-18. Print 2019 Mar 1.
7
Immune approaches for the prevention of breast milk transmission of HIV-1.预防HIV-1通过母乳传播的免疫方法。
Adv Exp Med Biol. 2012;743:185-95. doi: 10.1007/978-1-4614-2251-8_13.
8
PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi.PedVacc 002:一项针对内罗毕地区人类免疫缺陷病毒1型阳性母亲所生婴儿接种MVA.HIVA疫苗的I/II期随机临床试验。
Vaccine. 2014 Oct 7;32(44):5801-8. doi: 10.1016/j.vaccine.2014.08.034. Epub 2014 Aug 27.
9
Human Immunodeficiency Virus Treatment and Prevention for Pregnant and Postpartum Women in Global Settings.全球范围内孕产妇的人类免疫缺陷病毒治疗和预防。
Obstet Gynecol Clin North Am. 2022 Dec;49(4):693-712. doi: 10.1016/j.ogc.2022.07.002.
10
Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses.母体广谱且强效抗体应答背景下的垂直 HIV-1 传播。
J Virol. 2022 Jun 8;96(11):e0023122. doi: 10.1128/jvi.00231-22. Epub 2022 May 10.

本文引用的文献

1
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.高单克隆中和滴度降低了抗体介导预防试验中的突破性 HIV-1 病毒载量。
Nat Commun. 2023 Dec 14;14(1):8299. doi: 10.1038/s41467-023-43384-y.
2
The inclusion of pregnant women in vaccine clinical trials: An overview of late-stage clinical trials' records between 2018 and 2023.将孕妇纳入疫苗临床试验:2018 年至 2023 年晚期临床试验记录概述。
Vaccine. 2023 Nov 22;41(48):7076-7083. doi: 10.1016/j.vaccine.2023.10.057. Epub 2023 Oct 28.
3
Anticipating HIV viral escape - resistance to active and passive immunization.
预测HIV病毒逃逸——对主动免疫和被动免疫的抗性。
Curr Opin HIV AIDS. 2023 Nov 1;18(6):342-348. doi: 10.1097/COH.0000000000000816. Epub 2023 Sep 7.
4
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《使用尼赛珠单抗预防婴幼儿呼吸道合胞病毒疾病:免疫实践咨询委员会的建议-美国,2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Aug 25;72(34):920-925. doi: 10.15585/mmwr.mm7234a4.
5
Broadly neutralizing antibodies for HIV treatment and cure approaches.广谱中和抗体在 HIV 治疗和治愈方法中的应用。
Curr Opin HIV AIDS. 2023 Jul 1;18(4):157-163. doi: 10.1097/COH.0000000000000802. Epub 2023 May 4.
6
Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV.消除 HIV 垂直传播的产后预防新方法。
Glob Health Sci Pract. 2023 Apr 28;11(2). doi: 10.9745/GHSP-D-22-00401.
7
Antiretroviral Treatment of HIV/AIDS During Pregnancy.孕期抗逆转录病毒治疗艾滋病毒/艾滋病
JAMA. 2023 Apr 18;329(15):1308-1309. doi: 10.1001/jama.2023.5076.
8
Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission.母体和婴儿中 HIV-1 Env 特异性抗体的 Fc 受体结合可预测垂直传播减少。
Front Immunol. 2022 Dec 12;13:1051501. doi: 10.3389/fimmu.2022.1051501. eCollection 2022.
9
Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1.利用抗原优先性进行孕产妇疫苗接种以预防HIV-1母婴传播。
NPJ Vaccines. 2022 Jul 30;7(1):87. doi: 10.1038/s41541-022-00505-w.
10
Monoclonal antibody therapies against SARS-CoV-2.针对 SARS-CoV-2 的单克隆抗体疗法。
Lancet Infect Dis. 2022 Nov;22(11):e311-e326. doi: 10.1016/S1473-3099(22)00311-5. Epub 2022 Jul 5.